Contineum Therapeutics, Inc. (CTNM)
11.55
-0.03
(-0.26%)
USD |
NASDAQ |
Dec 16, 16:00
11.77
+0.22
(+1.90%)
After-Hours: 20:00
Contineum Therapeutics Total Assets (Quarterly): 190.85M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 1.056B |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| CG Oncology, Inc. | 729.91M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.38M |
| Shareholders Equity (Quarterly) | 180.47M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 29.07 |
| Net Debt Paydown Yield | -0.32% |